Kidney diseases are one of the leading causes of death in the United States, according to the Centers for Disease Control and Prevention. When the kidneys cannot filter blood properly, waste remains ...
New advances allow scientists to study DNA, RNA, and gene activity in individual cells rather than in bulk tissue samples.
Miplyffa was approved in September 2024 based on data from a clinical trial that showed arimoclomol plus miglustat slowed NPC disease progression.
A new study suggests that people with chronic kidney disease, type 2 diabetes, or both of these conditions may face an ...
People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.